Immunologic basis of allograft rejection and immunosuppressive agents in intestinal transplantation

Minerva Pediatrica

Volumn 61, Issue 3, 2009, Pages 293-303

  Vianna, R ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Graft rejection; Immunosuppressive agents; Intestinal diseases; Transplantation immunology

Indexed keywords

MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ENTEROPATHY; GASTROINTESTINAL SYMPTOM; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTESTINAL FAILURE; INTESTINE TRANSPLANTATION; LONG TERM CARE; LOOSE FECES; NAUSEA; REVIEW; RISK FACTOR; TREATMENT OUTCOME;

AUTOANTIBODIES; EVIDENCE-BASED MEDICINE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; INTESTINAL DISEASES; INTESTINE, SMALL; PATIENT SELECTION; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 67749113441     PISSN: 00264946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (78)

1. Murase N, Kim DG, Todo S, Cramer DV, Fung JJ, Starzl TE. Suppression of allograft rejection with FK506. I. Prolonged cardiac and liver survival in rats following short-course therapy. Transplantation 1990;50:186-189
2. Murase N, Kim DG, Todo S, Cramer DV, Fung J, Starzl TE.FK506 suppression of heart and liver allograft rejection. II: The induction of graft acceptance in rats. Transplantation 1990;50:739-744
3. Talukdar AJ, Ashokkumar C, Wilson P, Gupta A, Sun Q, Boig L et al. Lymphocyte subset reconstitution patterns in children with small bowel transplantation induced with steroid-free rabbit anti-human thymocyte globulin. Pediatr Transplant 2008 [Epub ahead of print].
4. Shah A, Agarwal A, Mangus R, Lim J, Fridell J, Vianna R et al. Induction immunosuppression with rabbit antithymocyte globulin in pediatric liver transplantation. Liver Transpl 2006;12:1210-1214 (Pubitemid 44194588)
5. Tzakis AG, Kato T, Nishida S, Levi DM, Tryphonopoulos P, Madariaga JR et al. Alemtuzumab (Campath-1H) combined with tacrolimus in intestinal and multivisceral transplantation. Transplantation 2003;75:1512-1517 (Pubitemid 36597287)
6. Abu-Elmagd KM, Costa G, Bond GJ, Wu T, Murase N, Zeevi A et al. Evolution of the immunosuppressive strategies for the intestinal and multivisceral recipients with special reference to allograft immunity and achievement of partial tolerance. Transpl Int 2009;22:96-109.
7. Beath SV. Closure and summary of Ninth International Small Bowel Transplantation Symposium. Transplant Proc 2006;38:1657-1658
8. Whitman WB, Coleman DC, Wiebe WJ. Prokaryotes: the unseen majority. Proc Natl Acad Sci U S A 1998;95:6578-83.
9. Brandtzaeg P, Baekkevold ES, Farstad IN, Jahnsen FL, Johansen FE, Nilsen EM et al. Regional specialization in the mucosal immune system: what happens in the microcompartments? Immunol Today 1999;20:141-151
10. Kerr MA. The structure and function of human IgA. Biochem J 1990;271:285-296
11. Brandtzaeg P, Pabst R. Let's go mucosal: communication on slippery ground. Trends Immunol 2004;25:570-7. (Pubitemid 39369732)
12. Crivellato E, Vacca A, Ribatti D. Setting the stage: an anatomist's view of the immune system. Trends Immunol 2004;25:210-217 (Pubitemid 38368168)
13. Eckmann L. Innate Immunity. In: Johnson L, editor. Physiology of the gastrointestinal tract, Vol.2. Burlington, MA: Elsevier, 2006. p. 1033-1057
14. Miller H, Zhang J, Kuolee R, Patel GB, Chen W. Intestinal M cells: the fallible sentinels? World J Gastroenterol 2007;13:1477-1486
15. Kraehenbuhl JP, Neutra MR. Epithelial M cells: differentiation and function. Annu Rev Cell Dev Biol 2000;16:301-332
16. Neutra MR, Mantis NJ, Kraehenbuhl JP. Collaboration of epithelial cells with organized mucosal lymphoid tissues. Nat Immunol 2001;2:1004-1009
17. Soderholm J, Perdue M. Effects of stress on intestinal mucosal function. In: Johnson LM, editor. Physiology of the gastrointestinal tract. Vol.1. Burlington, MA: Elsevier, 2006. p. 763-780
18. Sierro F, Pringault E, Assman PS, Kraehenbuhl JP, Debard N.Transient expression of M-cell phenotype by enterocyte-like cells of the follicle-associated epithelium of mouse Peyer's patches. Gastroenterology 2000;119:734-743
19. Sminia T, Wilders MM, Janse. Antigen-processing cells in gut associated lymphoid tissue (GALT). Cell Biol Int Rep 1983;7:677.
20. Cebra JJ, Periwal SB, Lee G, Lee F, Shroff KE. Development and maintenance of the gut-associated lymphoid tissue (GALT): the roles of enteric bacteria and viruses. Dev Immunol 1998;6:13-18 (Pubitemid 28409860)
21. Pavli P, Woodhams CE, Doe WF, Hume DA. Isolation and characterization of antigen-presenting dendritic cells from the mouse intestinal lamina propria. Immunology 1990;70:40-47 (Pubitemid 20148061)
22. Iwasaki A, Kelsall BL. Mucosal immunity and inflammation. I. Mucosal dendritic cells: their specialized role in initiating T cell responses. Am J Physiol 1999;276(5 Pt 1):G1074-8.
23. Sato A, Iwasaki A. Peyer's patch dendritic cells as regulators of mucosal adaptive immunity. Cell Mol Life Sci 2005;62:1333-1338 (Pubitemid 40853820)
24. Liu L, MacPherson GG. Dendritic cells in vivo: their role in the initiation of intestinal immune responses. Adv Exp Med Biol 1995;371A:271-274
25. Johansson C, Kelsall BL. Phenotype and function of intestinal dendritic cells. Semin Immunol 2005;17:284-94. (Pubitemid 40981933)
26. Takeda K. Evolution and integration of innate immune recognition systems: the Toll-like receptors. J Endotoxin Res 2005;11:51-55 (Pubitemid 40533080)
27. Fischer M, Ehlers M. Toll-like receptors in autoimmunity. Ann N Y Acad Sci 2008;1143:21-34.
28. Takeda K, Akira S. Toll-like receptors. Curr Protoc Immunol 2007; Chapter 14:Unit 14 12.
29. Granucci F, Ricciardi-Castagnoli P. Interactions of bacterial pathogens with dendritic cells during invasion of mucosal surfaces. Curr Opin Microbiol 2003;6:72-76 (Pubitemid 36258540)
30. O'Mahoni L. Immunology of the small intestine. In: Langnas A, Goulet O, editors. Intestinal failure. Vol.1. Oxford, UK: Blackwell, 2008; p. 33-44.
31. Riol-Blanco L, Sanchez-Sanchez N, Torres A, Tejedor A, Narumiya S, Corbí AL et al. The chemokine receptor CCR7 activates in dendritic cells two signaling modules that independently regulate chemotaxis and migratory speed. J Immunol 2005;174:4070-4080 (Pubitemid 40395983)
32. Sánchez-Sánchez N, Riol-Blanco L, de la Rosa G, Puig-Kröger A, García-Bordas J, Martín D et al. Chemokine receptor CCR7 induces intracellular signaling that inhibits apoptosis of mature dendritic cells. Blood 2004;104:619-625
33. Rossi M, Young JW. Human dendritic cells: potent antigen-presenting cells at the crossroads of innate and adaptive immunity. J Immunol 2005;175:1373-1381 (Pubitemid 41023036)
34. O'Garra A, Vieira P. Regulatory T cells and mechanisms of immune system control. Nat Med 2004;10:801-5. (Pubitemid 39070850)
35. Probst HC, Lagnel J, Kollias G, van den Broek M. Inducible transgenic mice reveal resting dendritic cells as potent inducers of CD8+ T cell tolerance. Immunity 2003;18:713-720 (Pubitemid 36588587)
36. Probst HC, McCoy K, Okazaki T, Honjo T, van den Broek M. Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4. Nat Immunol 2005;6:280-286 (Pubitemid 41724765)
37. Vianna RM, Mangus RS, Tector AJ. Current status of small bowel and multivisceral transplantation. Adv Surg 2008;42:129-150
38. Grant D. Intestinal Transplant registry; 2007.
39. Lee RG, Nakamura K, Tsamandas AC, Abu-Elmagd K, Furukawa H, Hutson WR et al. Pathology of human intestinal transplantation. Gastroenterology 1996;110:1820-1834
40. Butcher EC, Picker LJ. Lymphocyte homing and homeostasis. Science 1996;272:60-66
41. Clark CL. The immune response in small bowel transplantation. Ann R Coll Surg Engl 1996;78:97-102. (Pubitemid 26083626)
42. Webster GA, Bowles MJ, Wood RF, Pockley AG. Identification of host cells infiltrating graft Peyer's patches after fully allogeneic rat small bowel transplantation. Transplant Proc 1996;28:2452.
43. Newell K, Fryer J. Immunology of intestinal allograft rejection. In: Langnas A, editor. Intestinal failure. Vol.1. Oxford, UK: Blackwell, 2008. p. 314-321
44. Lakkis FG, Arakelov A, Konieczny BT, Inoue Y. Immunologic 'ignorance' of vascularized organ transplants in the absence of secondary lymphoid tissue. Nat Med 2000;6:686-688
45. Iwaki Y, Starzl TE, Yagihashi A, Taniwaki S, Abu-Elmagd K, Tzakis A et al. Replacement of donor lymphoid tissue in small-bowel transplants. Lancet 1991; 337:818-9.
46. Adams DH. Immunologic aspects of small bowel transplantation. Transplant Proc 1998;30:2557-2559
47. Adams DH, Shaw S. Leucocyte-endothelial interactions and regulation of leucocyte migration. Lancet 1994;343:831-836 (Pubitemid 24147515)
48. Pirsch JD, D'Alessandro AM, Sollinger HW, Hoffmann RM, Roecker E, Voss BJ et al. The effect of donor age, recipient age, and HLA match on immunologic graft survival in cadaver renal transplant recipients. Transplantation 1992;53:55-59
49. Opelz G, Wujciak T. The influence of HLA compatibility on graft survival after heart transplantation. The Collaborative Transplant Study. N Engl J Med 1994;330:816-819
50. Ruiz P, Garcia M, Pappas P, Berney T, Esquenazi V, Kato T et al. Mucosal vascular alterations in isolated small-bowel allografts: relationship to humoral sensitization. Am J Transplant 2003;3:43-49 (Pubitemid 36306822)
51. de Serre NP, Canioni D, Lacaille F, Talbotec C, Dion D, Brousse N et al. Evaluation of c4d deposition and circulating antibody in small bowel transplantation. Am J Transplant 2008;8:1290-1296 (Pubitemid 351763676)
52. Demetris AJ, Murase N, Lee RG, Randhawa P, Zeevi A, Pham S et al. Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts. Ann Transplant 1997;2:27-44.
53. Pirenne J, Kawai M. The protective effect of the liver: does it apply to the bowel too? Transplantation 2006;81:978-979
54. Abu-Elmagd K, Reyes J, Bond G, Mazariegos G, Wu T, Murase N et al. Clinical intestinal transplantation: a decade of experience at a single center. Ann Surg 2001;234:404-16; discussion 416-417 (Pubitemid 32847077)
55. Parizhskaya M, Redondo C, Demetris A, Jaffe R, Reyes J, Ruppert K et al. Chronic rejection of small bowel grafts: pediatric and adult study of risk factors and morphologic progression. Pediatr Dev Pathol 2003;6:240-250 (Pubitemid 36676961)
56. Heeckt PF, Halfter WM, Schraut WH, Bauer AJ. Chronic rejection alters morphology and function of orthotopic and heterotopic small bowel grafts. Transplant Proc 1994;26:1512.
57. Bonnefoy-Berard N, Flacher M, Revillard JP. Antiproliferative effect of antilymphocyte globulins on B cells and B-cell lines. Blood 1992;79:2164-2170
58. Beiras-Fernandez A, Thein E, Hammer C. Induction of immunosuppression with polyclonal antithymocyte globulins: an overview. Exp Clin Transplant 2003;1:79-84.
59. Reyes J, Mazariegos GV, Abu-Elmagd K, Macedo C, Bond GJ, Murase N, Peters J, Sindhi R, Starzl TE et al. Intestinal transplantation under tacrolimus monotherapy after perioperative lymphoid depletion with rabbit anti-thymocyte globulin (thymoglobulin). Am J Transplant 2005;5:1430-1436
60. Bond GJ, Mazariegos GV, Sindhi R, Abu-Elmagd KM, Reyes J. Evolutionary experience with immunosuppression in pediatric intestinal transplantation. J Pediatr Surg 2005;40:274-9; discussion 279-280 (Pubitemid 40143571)
61. Vianna RM, Mangus RS, Fridell JA, Weigman S, Kazimi M, Tector J. Induction immunosuppression with thymoglobulin and rituximab in intestinal and multivisceral transplantation. Transplantation 2008;85:1290-1293 (Pubitemid 351670479)
62. Jordan SC, Pescovitz MD. Presensitization: the problem and its management. Clin J Am Soc Nephrol 2006;1:421-32.
63. Quintini C, Kato T, Gaynor JJ, Ueno T, Selvaggi G, Gordon P et al. Analysis of risk factors for the development of posttransplant lymphoprolipherative disorder among 119 children who received primary intestinal transplants at a single center. Transplant Proc 2006;38:1755-1758 (Pubitemid 44190042)
64. Tzakis AG, Kato T, Nishida S, Levi DM, Madariaga JR, Nery JR et al. Preliminary experience with campath 1H (C1H) in intestinal and liver transplantation. Transplantation 2003;75:1227-1231 (Pubitemid 36513025)
65. Nishida S, Levi DM, Moon JI, Madariaga JR, Kato T, Selvaggi G et al. Intestinal transplantation with alemtuzumab (Campath-1H) induction for adult patients. Transplantation Proceedings 2006;38:1747-1749 (Pubitemid 44190058)
66. Lauro A, Amaduzzi A, Dazzi A, Ercolani G, Zanfi C, Golfieri L et al. Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: A comparison of two different regimens on 29 recipients during the early post-operative period. Dig Liver Dis 2007;39:253-256 (Pubitemid 46196441)
67. Magliocca JF, Knechtle SJ. The evolving role of alemtuzumab (Campath-1H) for immunosuppressive therapy in organ transplantation. Transpl Int 2006;19:705-14.
68. Riechmann L, Clark M, Waldmann H, Winter G. Reshaping human antibodies for therapy. Nature 1988;332:323-327
69. Webster AC, Woodroffe RC, Taylor RS, Chapman JR, Craig JC. Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data. BMJ 2005;331:810.
70. Patel JK, Kobashigawa JA. Tacrolimus in heart transplant recipients: an overview. BioDrugs 2007;21:139-143 (Pubitemid 46827847)
71. A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. The U.S. Multicenter FK506 Liver Study Group. N Engl J Med 1994;331:1110-1115
72. Moore R, Lord R. Tacrolimus (FK506) versus cyclosporin in prevention of liver allograft rejection. Lancet 1994;344:948. (Pubitemid 24295886)
73. Vianna RM, Mangus RS, Fridell JA, Kazimi M, Hollinger E, Tector J. Initiation of an intestinal transplant program: the Indiana experience. Transplantation 2008;85:1784-1790
74. Kato T, Tzakis AG, Selvaggi G, Gaynor JJ, Takahashi H, Mathew J et al. Intestinal and multivisceral transplantation in children. Ann Surg 2006;243:756-64; discussion 764-766 (Pubitemid 44297478)
75. Alessiani M, Cillo U, Fung JJ, Irish W, Abu-Elmagd K, Jain A et al. Adverse effects of FK 506 overdosage after liver transplantation. Transplant Proc 1993;25(1 Pt 1):628-634 (Pubitemid 23082500)
76. Wallemacq P, Armstrong VW, Brunet M, Haufroid V, Holt DW, Johnston A et al. Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference. Ther Drug Monit 2009;31:139-152
77. Fishbein TM, Florman S, Gondolesi G, Schiano T, LeLeiko N, Tschemia A et al. Intestinal transplantation before and after the introduction of sirolimus. Transplantation 2002;73:1538-1542
78. Florman S, Gondolesi G, Schiano T, Tschernia A, LeLeiko N, Kaufman SS et al. Improved results in small bowel transplantation using sirolimus. Transplant Proc 2002;34:936. (Pubitemid 34556867)